Why is Lotus Eye Hospit falling/rising?

As of 17-Sep, Lotus Eye Hospital & Institute Ltd is currently priced at 122.25, reflecting an increase of 0.95, or 0.78%. The stock has shown strong performance over the past month, with a return of 59.47%, and has outperformed the BSE500 over various timeframes, including a 63.07% return in the last year. However, today's trading indicates a decline in investor participation, with delivery volume dropping by 17.47% compared to the 5-day average. Despite this, the stock remains liquid enough for trading, and its low debt-to-equity ratio suggests financial stability, contributing to its hold status.
In the broader market context, the stock's performance over the past week has been negative at -1.37%, contrasting with the Sensex, which has gained 1.56%. This short-term underperformance may be attributed to the recent drop in investor participation, despite the stock's strong long-term returns. Overall, while Lotus Eye Hospital has demonstrated impressive growth over the longer term, the recent decline in trading volume and short-term performance relative to the benchmark indicates a mixed outlook in the current market environment.